Biogen Inc - Company Profile
Powered by 
All the data and insights you need on Biogen Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Biogen Inc Strategy Report
- Understand Biogen Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreBusiness Description
Biogen Inc (Biogen) discovers, develops, and delivers drugs for the treatment of serious neurological and neurodegenerative diseases, including multiple sclerosis (MS) and neuroimmunology; Alzheimer’s disease and dementia; movement disorders and neuromuscular disorders such as spinal muscular atrophy and amyotrophic lateral sclerosis; ophthalmology; pain; neuropsychiatry; and acute neurology. It also manufactures and commercializes biosimilars of advanced biologics.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Biogen conducts R&D to provide innovative products in the areas of MS and neuroimmunology, Alzheimer's disease and dementia, Parkinson's disease and movement disorders, neuromuscular diseases, neuropsychiatry, specialized immunology, pain, ophthalmology, acute neurology, multiple sclerosis, neurovascular, genetic neurodevelopmental disorders, and systemic lupus erythematosus. The company’s pipeline products Lecanemab, Zuranolone, Dapirolizumab, Litifilimab, and others The company spent US$2,459.5 million on its R&D activities in FY2023, indicating 10.4% of the total revenue. The company holds several US and Europe patents and patent applications, and several corresponding foreign counterparts, related to Avonex, Plegridy, Tecfidera, Tysabri, Vumerity, Fampyra, Zinbryta, Aduhelm, Leqembi, and Spinraza.
Product Categories
Overview
Receives operating profit from the collaborations of Rituxan Hycela, and Gazyva and royalty revenue on sales of Ocrevus.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers products for the treatment of severe rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, moderate to severe plaque psoriasis, paediatric crohn's disease, moderate to severe crohn's disease, severe ulcerative colitis and severe ankylosing spondylitis. Key products include Benepali, Flixabi and Imraldi.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Develops, manufactures and markets several products to treat patients with MS across the US, Canada, France, Germany, Italy, Japan, Spain and the UK. Key products include Avonex, Tysabri, Tecfidera, Fumarate, Interferon, Fampyra and Plegridy. Views agreements and collaborations are major growth drivers for the category.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers medicines for severe plaque psoriasis. Key product includes Fumaderm.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers products for the treatment of Rare Disease. Key product includes Spinraza.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer